Therapeutic applications of urease inhibitors.
作者信息
Rosenstein I
出版信息
J Antimicrob Chemother. 1982 Sep;10(3):159-61. doi: 10.1093/jac/10.3.159.
PMID:7142070
Abstract
摘要
相似文献
1
Therapeutic applications of urease inhibitors.脲酶抑制剂的治疗应用。
J Antimicrob Chemother. 1982 Sep;10(3):159-61. doi: 10.1093/jac/10.3.159.
2
Inhibition of bacterial urease.
Invest Urol. 1973 Nov;11(3):234-8.
3
Infection stones and the role of bacterial urease.感染性结石与细菌脲酶的作用
J Infect. 1980 Sep;2(3):211-4. doi: 10.1016/s0163-4453(80)90578-2.
4
Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
J Pharmacobiodyn. 1981 Jul;4(7):469-74. doi: 10.1248/bpb1978.4.469.
5
Inhibitors of urease as chemotherapeutic agents.
Crit Rev Microbiol. 1984;11(1):1-12. doi: 10.3109/10408418409105901.
6
Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.脲酶在变形杆菌引起的尿路感染所致肾盂肾炎中的作用。
J Infect Dis. 1975 Feb;131(2):177-81. doi: 10.1093/infdis/131.2.177.
7
Benurestat, a urease inhibitor for the therapy of infected ureolysis.贝奴司他，一种用于治疗感染性尿素分解的脲酶抑制剂。
Invest Urol. 1975 Mar;12(5):381-6.
8
Prevention of infected urinary stones by urease inhibition.
Invest Urol. 1973 Nov;11(3):228-33.
9
Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids.
J Pharmacobiodyn. 1980 Sep;3(9):451-6. doi: 10.1248/bpb1978.3.451.
10
Propionohydroxamic acid in the treatment of urease-induced calculi. Six months follow-up of 19 patients.丙酰氧肟酸治疗脲酶诱导结石。19例患者的6个月随访
Contrib Nephrol. 1987;58:212-4. doi: 10.1159/000414520.
Zotero 插件